Pancreatic Cancer Research

ResearcherHarvard UniversityActive in the last 2 years

Michèle Moreau

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6881-6300; OpenAlex author ID A5051155148. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2018: 1 paper · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 3

  1. Leveraging the Immune Response from LIFE Biomaterial and Photon-Flash in Pre-Clinical Pancreatic Cancer Treatment. Co-author DOI 10.3390/pharmaceutics17101273↗
  2. Flavonoid Derivative of Cannabis Demonstrates Therapeutic Potential in Preclinical Models of Metastatic Pancreatic Cancer. Co-author DOI 10.3389/fonc.2019.00660↗
  3. Radiation and Local Anti-CD40 Generate an Effective in situ Vaccine in Preclinical Models of Pancreatic Cancer. Co-author DOI 10.3389/fimmu.2018.02030↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Wilfred F. Ngwa · 3 shared papers, 2018–2025 · strength 0.41
  2. Kai Ding · 1 shared paper, 2025 · strength 0.22
  3. Amol Kumar Narang · 1 shared paper, 2025 · strength 0.22
  4. Sayeda Yasmin‐Karim · 2 shared papers, 2018–2019 · strength 0.18
  5. Stephanie K. Dougan · 1 shared paper, 2018 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.